Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HDAC Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00995332
What this trial is testing

Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose Cytarabine

Who this might be right for
Acute Myelogenous Leukemia
University of Bergen 36
Testing effectiveness (Phase 2)WithdrawnNCT03873025
What this trial is testing

CXD101 in Combination With Pembrolizumab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
University College, London
Early research (Phase 1)Study completedNCT00015925
What this trial is testing

MS-275 in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Study completedNCT02181218
What this trial is testing

Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas

Who this might be right for
Lymphoma, T-Cell, CutaneousLymphoma, T-Cell, PeripheralHodgkin Disease+1 more
Washington University School of Medicine 24
Early research (Phase 1)Study completedNCT01059552
What this trial is testing

Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Locally Advanced Non-small Cell Lung Cancer
Fox Chase Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00339196
What this trial is testing

5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS

Who this might be right for
Acute Myelogenous Leukaemia (AML)Myelodysplastic Syndrome (MDS)
Assistance Publique - Hôpitaux de Paris 25
Early research (Phase 1)Study completedNCT00739414
What this trial is testing

Dose-escalating Study of LBH589 in Adult Patients With Advanced Solid Tumors

Who this might be right for
CancerAdvanced Solid Tumor
Novartis Pharmaceuticals 14
Early research (Phase 1)Study completedNCT00926640
What this trial is testing

A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers

Who this might be right for
Carcinoma NeuroendocrineSmall Cell Lung CarcinomaMalignant Epithelial Neoplasms
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)UnknownNCT01589809
What this trial is testing

Effect of Nicotinamide in Friedreich's Ataxia

Who this might be right for
Neurodegenerative Disorders
Imperial College London 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05694936
What this trial is testing

Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Australasian Gastro-Intestinal Trials Group 38
Early research (Phase 1)Study completedNCT01344707
What this trial is testing

Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)

Who this might be right for
Advanced Hematologic Malignancies
4SC AG 36
Early research (Phase 1)Study completedNCT02032810
What this trial is testing

Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma

Who this might be right for
MelanomaSkin Cancer
H. Lee Moffitt Cancer Center and Research Institute 17
Large-scale testing (Phase 3)UnknownNCT02902185
What this trial is testing

Chidamide in Combination With ART for Reactivation of the Latent HIV-1 Reservoir

Who this might be right for
Chronic HIV Infections
Tang-Du Hospital 60
Very early researchWithdrawnNCT00993642
What this trial is testing

ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer

Who this might be right for
Breast Cancer
Tulane University Health Sciences Center
Testing effectiveness (Phase 2)WithdrawnNCT02756663
What this trial is testing

Panobinostat in Combination With Carfilzomib and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT02805660
What this trial is testing

Phase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLC

Who this might be right for
Advanced Cancer
Mirati Therapeutics Inc. 83
Early research (Phase 1)Study completedNCT02616874
What this trial is testing

Study to Evaluate the Safety and Effect of HIVconsv Vaccines in Combination With Histone Deacetylase Inhibitor Romidepsin on the Viral Rebound Kinetic After Treatment Interruption in Early Treated HIV-1 Infected Individuals

Who this might be right for
HIV
IrsiCaixa 15
Testing effectiveness (Phase 2)Study completedNCT00134043
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer

Who this might be right for
Insular Thyroid CancerRecurrent Thyroid CancerStage II Follicular Thyroid Cancer+4 more
National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT00412997
What this trial is testing

LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma

Who this might be right for
TumorsCutaneous T-Cell Lymphoma
Novartis 14
Early research (Phase 1)Study completedNCT02307240
What this trial is testing

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Who this might be right for
Triple-Negative Breast CancerHigh-grade Serous Ovarian CancerSolid Tumors+1 more
Curis, Inc. 43
Next Page